MedReg 2023: Annual Medical Device Regulatory Confex – Where Regulatory Excellence Meets Virtual Engagement – ResearchAndMarkets.com
The “MedReg 2023 – Annual Medical Device Regulatory Confex” training has been added to ResearchAndMarkets.com’s offering. Step into the realm of regulatory excellence at MedReg 2023, the Annual Medical Devices Regulatory Confex that will revolutionize your understanding of medical device regulations. Get ready for…
AGIC Capital Completes Growth Equity Investment into AP Technologies
AGIC Capital (“AGIC”), a growth-oriented European-Asian private equity firm with $2.2 billion of assets under management has completed the investment of an undisclosed amount into AP Technologies (“AP Tech”), an emerging medical device contract manufacturer focusing on highly-engineered solutions for…
DermaSensor Study Results For Skin Cancer Detection Device Performance Across Skin Tones Of Over 1,000 Patients
DermaSensor Inc., a health technology company equipping primary care physicians (PCPs) with a non-invasive device for evaluating suspicious skin lesions, presented today promising results from a sub-analysis of the DERM-SUCCESS study.1 The analysis focused on the performance of DermaSensor’s handheld Elastic…
Henry Schein Opens Customer Assistance Hotline in Response to Hawaii Wildfires
Henry Schein, Inc. (Nasdaq: HSIC) reminds its customers in Hawaii that the Henry Schein Customer Assistance Hotline is open for dentists and physicians who may experience operational, logistical, or financial issues as a result of damage caused by the recent…
CORRECTING and REPLACING Children’s Health Ireland and Oneview Healthcare partner to deliver Digital Patient Engagement And Education System
Third Paragraph, first sentence of release dated August 10, 2023 should read: Implementation of the Digital Patient Engagement and Education System will commence in Q3 2023. The updated release reads: CHILDREN’S HEALTH IRELAND AND ONEVIEW HEALTHCARE PARTNER TO DELIVER DIGITAL…
David Maman and Divya Chander to Keynote CharmHealth Third Annual Innovation Challenge & Showcase
CharmHealth, a leading provider of healthcare technology solutions, today announced that Binah.ai CEO and Founder David Maman and Divya Chander, chair of neuroscience, faculty in medicine at Singularity University, will be the keynote speakers for the 2023 Innovation Challenge. Maman and Chander will address…
Artificial Intelligence and Machine Learning Powered Signal Management Training: A Course for Visionaries – Unlocking the Potential of AI and ML in Drug Safety – ResearchAndMarkets.com
The “Artificial Intelligence and Machine Learning Powered Signal Management Training Course” conference has been added to ResearchAndMarkets.com’s offering. The quest to find precise evidence to answer complex questions from biomedicine and Healthcare for Drug Safety has brought us to a major crossroads. With the…
CareDx Comments on Issuance of Proposed LCD for Molecular Testing for Solid Allograft Rejection
CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today commented on the issuance of proposed changes to the Local Coverage…
CAS and Molecule.one Announce Strategic Collaboration to Accelerate Drug Discovery
CAS is the American Chemical Society’s specialized division for scientific information solutions and Molecule.one is the Leading company in biotechnology. The two institutions have entered into a strategic collaboration focused on the joint development of computer-aided synthetic design techniques to accelerate…
Appili Therapeutics Reports Financial and Operational Results for First Quarter of Fiscal Year 2024
Appili Therapeutics Inc. (TSX:APLI; OTCQB: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases and biodefense products, today announced its financial and operational results for the first quarter of its fiscal year 2024, which…
Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced the grant of inducement awards to three new employees. The Compensation Committee of the Board of Directors of Marinus…
HDL Therapeutics to Go Public in Merger with Swiftmerge Acquisition Corp.
HDL Therapeutics, Inc. (“HDL Therapeutics”), a privately held commercial stage biotech company with an FDA-approved cardiovascular therapy the Plasma Delipidation System (PDS-2™ System) for reducing coronary atheroma in patients with homozygous familial hypercholesterolemia (HoFH), has signed a definitive merger agreement…